| |
2006 |
- Signed licencing agreement with GE Healthcare for Hexvix
- Hexvix launched in Europe |
| |
2005 |
- Hexvix approved in all EU/EEA countries
- Hexvix launched in the Nordic region
- NDA filed for Hexvix in the US |
| |
2004 |
- First marketing authorisation obtained for Hexvix |
| |
2003 |
- Galderma's first Metvix launch |
| |
2002 |
- First marketing authorisation application filed for Hexvix |
| |
2001 |
- First marketing authorisation obtained for Metvix
- Metvix and Aktilite marketed for the first time
- Licensing agreement for Metvix signed with Galderma |
| |
2000 |
- First marketing authorisation application filed for Metvix
- Listing of the company's share on the Oslo Stock Exchange
- Start of Hexvix clinical studies
|
| |
1997 |
- Recruited first full-time employee
- Start of formal clinical studies for Metvix |